Why is the EU introducing the E-Evidence package? The answer lies in the growing role of electronic evidence in criminal investigations. As more data is stored electronically, often in the cloud, this data becomes harder.

The Supreme Court ("Hof van Cassatie/Court of Cassation") overruled on 26 May 2023 a decision that determined that Article 1722 (old) Civil Code (a partial or total "destruction" of the leased premises)...

The European Commission often relies on scientific evidence for its regulatory decisions. But when challenged, how much deference is owed to the regulator's interpretation of the underlying science?

The Court of Justice of the European Union has delivered a landmark judgment addressing whether political parody and freedom of expression can justify the unauthorized use of a famous trade mark. When Belgian political party Vlaams Belang appropriated IKEA's distinctive branding to promote its immigration reform programme, the resulting legal battle forced European courts to balance fundamental rights: the trade mark owner's property rights against the political actor's freedom of expression.

On 14 June 2023, the European Parliament adopted its position on the draft AI Act, which brings one step closer an EU regulation for generative AI and other AI systems.

On 21 September 2024, the Chief Public Prosecutor of the Belgian Competition authority ("BCA") publicly announced that in the BCA's investigations into agreements concerning subsidies granted for the delivery...

Benchmarking is a vital tool in the development and improvement of a franchise network, and will benefit franchisees and franchisors alike.

What every posting employer and (Belgian) service user should know about Checkinatwork.

Promotions and price reductions are powerful tools in the retail sector, and are subject to legal regulations. From sales and liquidation sales to special offers, coupons, contests and price comparisons...

The European Commission published a draft proposal for a revised Product Liability Directive (the "PLD Proposal") on 28 September 2022, which aims to bring the European Union's...

The EU Deforestation Regulation (‘EUDR') was published in the Official Journal on 9 June 2023 and entered into force on 29 June 2023, marking the start of its implementation phase.

After companies with at least 250 employees have already had to do so, it is now the turn of companies with at least 50 employees to set up an internal reporting channel as the 17 December 2023...

What every posting employer and (Belgian) service user should know about joint committees.

A key point that market participants should be clear on from the outset: AIFMD II brings changes to the regulatory framework applicable to both Alternative Investment Funds (AIFs)...

The Belgian legislator has completed the implementation of AIFMD II through the Law of 22 July 2026, introducing significant regulatory changes for investment funds and their managers. Beyond the mandatory transposition, Belgium has introduced welcome flexibilities including expanded permitted activities for UCITS management companies and AIFMs, streamlined share class creation processes, and relaxed fit and proper requirements for certain fund managers.

The intersection of pharmaceutical advertising, consumer protection, and internal market freedoms remains a complex legal battleground within the EU. In Apothekerkammer Nordrhein v. DocMorris NV (C-517/23)...

The Cannabis sativa L. plant serves a wide range of purposes, many of which are uncontroversial. It can be grown in the EU, in which context it is commonly called ‘hemp'.

On 7 December 2023, the EU Court of Justice (‘CJEU') handed down its ruling in case C-830/21 between Syngenta Agro GmbH (‘Syngenta Agro') and Agro Trade Handelsgesellschaft...

Belgium's federal Chamber of Representatives has adopted a comprehensive bill introducing significant changes to pharmaceutical reimbursement procedures, including simplified approval tracks, new combination therapy rules, and an 80 million EUR annual industry contribution. The legislation also addresses drug unavailability issues and postpones certain 2024 reforms until 2028, fundamentally reshaping the financial and operational landscape for pharmaceutical companies operating in Belgium.

In Case T‑278/25, the EU General Court recently dismissed as inadmissible a challenge brought by a patient advocacy association against the European Commission's refusal to renew the conditional...